Reditux RA 500 mg Injection
$479.94
$138.71
Reditux RA 500 mg Injection is a powerful monoclonal antibody specifically designed to target and treat various immune system-related conditions. Primarily indicated for certain malignancies, it plays a crucial role in the management of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By binding to CD20 antigens on the surface of B-cells, Reditux effectively disrupts the growth of cancerous cells, thereby aiding in the reduction of tumor size and improving patient outcomes. It’s important to note that patients receiving this treatment should be monitored for potential infusion reactions, infections, and other side effects, as the drug can compromise immune function. Prior to administration, healthcare providers should conduct a thorough assessment to ensure it is suitable for the patient's specific health profile. As a vital option in oncological therapy, Reditux RA 500 mg Injection represents a significant advancement in cancer treatment, enhancing the quality of life for many patients. Always consult with a healthcare professional to discuss the benefits and risks associated with this medication.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Reditux ra 500 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system, and the medication helps target and destroy cancerous B cells. By using Reditux, healthcare providers aim to manage the disease effectively and improve patient outcomes. Its administration is often part of a comprehensive treatment plan tailored to individual needs.
• In patients with rheumatoid arthritis, Reditux ra 500 mg injection is employed to reduce inflammation and slow disease progression. This medication works by targeting specific cells involved in the autoimmune response, helping to alleviate symptoms and improve joint function. By incorporating Reditux into the treatment regimen, physicians can enhance the quality of life for individuals suffering from this chronic condition. It is often used in cases where other therapies have proven insufficient.
• Reditux ra 500 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL), a type of blood cancer characterized by the accumulation of abnormal lymphocytes. This medication helps to eliminate these malignant cells, contributing to better disease management. Patients receiving Reditux may experience a reduction in disease-related symptoms and improved overall health. It is an important option for those diagnosed with CLL.
• Additionally, Reditux ra 500 mg injection is utilized in treating conditions such as granulomatosis with polyangiitis and microscopic polyangiitis. These are autoimmune disorders that affect blood vessels and can lead to severe complications. By administering Reditux, healthcare professionals aim to suppress the inappropriate immune response and promote remission. This therapy plays a crucial role in managing these complex conditions, allowing for better patient outcomes.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Reditux 500 mg Vial has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Rituximab Injection 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Reditux RA 500 mg is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Reditux Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Reditux RA 500 mg reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Reditux RA 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Reditux 500 mg Vial is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituximab Injection 500 mg. Please consult your doctor.
• Kidney: Reditux RA 500 mg is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Reditux RA 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Reditux 500 mg Vial is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Anti-cancer Drug Reditux may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituximab Injection 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.